#9449
#9450
Re: Farmas USA
#9451
Re: Farmas USA
#9452
Re: Farmas USA
#9453
Re: Farmas USA
#9454
Re: Farmas USA
#9455
Re: Farmas USA
AMRN, acojona un poco;
FDA is expected to issue an approval decision on AMR101 on or before July 26. The decision on the drug's NCE status should be announced at the same time. If FDA approves AMR101 but doesn't grant the drug NCE status, Amarin's stock price could fall on fears that generic drug makers will immediately file paragraph 4 challenges in an effort to invalidate AMR101's patents.
Fuente;
#9456